Manu Shankar-Hari

Manu Shankar-Hari

King's College

H-index: 68

North America-United States

About Manu Shankar-Hari

Manu Shankar-Hari, With an exceptional h-index of 68 and a recent h-index of 66 (since 2020), a distinguished researcher at King's College, specializes in the field of Sepsis, Critical Illness, ARDS, Precision Medicine, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations For Developing Precision Medicine in ICU

Antibiotics, Sedatives, and Catecholamines Further Compromise Sepsis-Induced Immune Suppression in Peripheral Blood Mononuclear Cells

Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypes

Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS)

Reframing Sepsis Immunobiology for Translation

Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies

Assessment of longitudinal changes in immune responses in critically ill adults with COVID-19

Stimulation of platelet P2Y1 receptors by different endogenous nucleotides leads to functional selectivity via biased signalling

Manu Shankar-Hari Information

University

Position

___

Citations(all)

63318

Citations(since 2020)

48696

Cited By

19599

hIndex(all)

68

hIndex(since 2020)

66

i10Index(all)

166

i10Index(since 2020)

161

Email

University Profile Page

Google Scholar

Manu Shankar-Hari Skills & Research Interests

Sepsis

Critical Illness

ARDS

Precision Medicine

Immunology

Top articles of Manu Shankar-Hari

From ICU Syndromes to ICU Subphenotypes: Consensus Report and Recommendations For Developing Precision Medicine in ICU

2024/4/30

Antibiotics, Sedatives, and Catecholamines Further Compromise Sepsis-Induced Immune Suppression in Peripheral Blood Mononuclear Cells

Critical Care Medicine

2024/4/1

Manu Shankar-Hari
Manu Shankar-Hari

H-Index: 33

Patient stratification using plasma cytokines and their regulators in sepsis: relationship to outcomes, treatment effect and leucocyte transcriptomic subphenotypes

Thorax

2024/3/12

Manu Shankar-Hari
Manu Shankar-Hari

H-Index: 33

Elevated ferritin, mediated by IL-18 is associated with systemic inflammation and mortality in acute respiratory distress syndrome (ARDS)

thorax

2024/3/1

Manu Shankar-Hari
Manu Shankar-Hari

H-Index: 33

Angela Rogers
Angela Rogers

H-Index: 26

Reframing Sepsis Immunobiology for Translation

The Lancet Respiratory Medicine

2024/2/23

Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies

2024/2/23

Assessment of longitudinal changes in immune responses in critically ill adults with COVID-19

2024/2/16

Stimulation of platelet P2Y1 receptors by different endogenous nucleotides leads to functional selectivity via biased signalling

British Journal of Pharmacology

2023/1/24

Temporal Trends in Mortality of Critically Ill Patients with Sepsis in the United Kingdom, 1988-2019

American Journal of Respiratory and Critical Care Medicine

2024/1/23

Manu Shankar-Hari
Manu Shankar-Hari

H-Index: 33

Long-term impact of COVID-19 hospitalisation among individuals with pre-existing airways diseases in the UK: a multicentre, longitudinal cohort study (PHOSP-COVID)

ERJ Open Research

2024/1/1

The genomic landscape of Acute Respiratory Distress Syndrome: a meta-analysis by information content of genome-wide studies of the host response.

medRxiv

2024

Bo Wang
Bo Wang

H-Index: 9

Manu Shankar-Hari
Manu Shankar-Hari

H-Index: 33

Publisher Correction: The effect of blood pressure on mortality following out‑of‑hospital cardiac arrest: a retrospective cohort study of the United Kingdom Intensive Care …

Critical Care

2023

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Nature

2023/5/25

Evolving management practices for early sepsis-induced hypoperfusion: a narrative review

2023/5/15

Manu Shankar-Hari
Manu Shankar-Hari

H-Index: 33

Phase 2 randomised placebo-controlled trial of spironolactone and dexamethasone versus dexamethasone in COVID-19 hospitalised patients in Delhi

BMC Infectious Diseases

2023/5/15

A randomised phase 2a study to investigate the effects of blocking interleukin-33 with tozorakimab in patients hospitalised with COVID-19: ACCORD-2

ERJ Open Research

2023/10/1

See List of Professors in Manu Shankar-Hari University(King's College)